Mortality and Ankylosing Spondylitis in the US population: leading causes and associated factors (2023)
https://doi.org/10.1007/s10067-023-06776-5

Disease characteristics, pathogenesis, and treatment controversies of axial psoriatic arthritis (2023)
https://doi.org/10.1016/j.jbspin.2023.105625

Clinical profile and treatment utilisation based on HLA-B*27 status in axial spondyloarthritis: results from ASAS-PerSpA study (2023)
https://doi.org/10.1136%2Frmdopen-2023-003179

Disease characteristics, pathogenesis, and treatment controversies of axial psoriatic arthritis (2023)
https://doi.org/10.1016/j.jbspin.2023.105625

Prevalence and distribution of peripheral muculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/33462157/

Clinical Manifestations and Diagnosis of Axial Spondyloarthritis. (2020)
https://pubmed.ncbi.nlm.nih.gov/33105312/

Understanding Barriers in the Pathway to Diagnosis of Ankylosing Spondylitis: Results From a US Survey of 1690 Physicians From 10 Specialties (2020)
https://pubmed.ncbi.nlm.nih.gov/33029932/

Recognizing Axial Spondyloarthritis: A Guide for Primary Care (2020)
https://pubmed.ncbi.nlm.nih.gov/32736944/

The American College of Rheumatology Fibromyalgia Criteria Are Useful in the Evaluation of Fibromyalgia Symptoms in Patients With Ankylosing Spondylitis: A Cross-Sectional Study (2020)
https://pubmed.ncbi.nlm.nih.gov/32701537/

Ixekizumab Improves Functioning and Health in the Treatment of Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results, COAST-X Trial (2020)
https://pubmed.ncbi.nlm.nih.gov/33044756/